...
首页> 外文期刊>Inorganica Chimica Acta >New heterobimetallic nickel(II) ferrocenyldithiophosphonato complexes: Syntheses, characterization, antiproliferative activity and X-ray, DFT, molecular docking studies on trans-bis-[O-3-methyl-1-butyl-(ferrocenyl) dithiophosphonato]nickel(II)
【24h】

New heterobimetallic nickel(II) ferrocenyldithiophosphonato complexes: Syntheses, characterization, antiproliferative activity and X-ray, DFT, molecular docking studies on trans-bis-[O-3-methyl-1-butyl-(ferrocenyl) dithiophosphonato]nickel(II)

机译:新的异质物质镍(II)二氧键苯基二硫代磷酸酯:对反双胞胎 - [O-3-甲基-1-丁基 - (二茂铁)二硫代磷酸镍(II)的合成,表征,抗增殖活性和X射线,DFT,分子对接研究]镍(II)

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Ferrocenyldithiophosphonate type ligands in salt forms, ([NH4(FcLn)], FcLn = Fc(RO)P(S)S; n = 1, R = 3-phenyl-1-propyl-; n = 2, R = 1-phenyl-1-propyl-; n = 3, R = 3-methyl-1-butyl-; n = 4, R = 3-pentyl-) were prepared and reacting them with Ni(II) salts, complexes of the general formula [Ni(FcLn)(2)] were obtained. They were further treated with pyridine (Py) to yield [Ni(FcLn)(2)(Py)(2)]. X-ray structure of the complex, [Ni(FcL(3))(2)] was elucidated. The density functional (DFT) and docking calculations on the same compound were also performed by using X-ray data. Docking studies showed a notable van der Waals interaction between the complex [Ni(FcL(3))(2)] and human DNA. The cytotoxic activities of the compounds [Ni(FcLn)(2)] against three human cancer cell lines (HepG2, DLD-1, MDA-MB-231) were investigated for finding new drug candidates. The results indicate that [Ni(FcL1)(2)] and [Ni(FcL2)(2)] complexes have a mild degree of antiproliferative activity against liver, colon and breast cancerous cell lines. That the activity is mild indicate that the docking sites on DNA are not crucially active in malign reproduction.
机译:盐形式的二茂铁基二硫代膦酸盐型配体,([NH4(FcLn)],FcLn=Fc(RO)P(S)S;n=1,R=3-苯基-1-丙基-;n=2,R=1-苯基-1-丙基-;n=3,R=3-甲基-1-丁基-;制备了n=4,R=3-戊基-)并与镍(II)盐反应,得到通式[Ni(FcLn)(2)]的配合物。用吡啶(Py)进一步处理,得到[Ni(FcLn)(2)(Py)(2)]。阐明了配合物[Ni(FcL(3))(2)]的X射线结构。利用X射线数据对同一化合物进行了密度泛函(DFT)和对接计算。对接研究表明,络合物[Ni(FcL(3))(2)]与人类DNA之间存在显著的范德华相互作用。为了寻找新的候选药物,研究了化合物[Ni(FcLn)(2)]对三种人类癌症细胞系(HepG2、DLD-1、MDA-MB-231)的细胞毒性活性。结果表明[Ni(FcL1)(2)]和[Ni(FcL2)(2)]复合物对肝、结肠和乳腺癌细胞系具有轻度的抗增殖活性。这种活性是温和的,这表明DNA上的对接位点在恶性生殖中并不具有关键活性。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号